Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metabolism of Deuterated NNN in Smokeless Tobacco Users
NCT02414477Phase 1Terminated
- Sponsor
- University of Minnesota
- Start
- Apr 2018
- Primary completion
- Feb 2020
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial, sponsored by University of Minnesota. Primary endpoint: Extent of alpha-hydroxylation of NNN at 1 week. Started Apr 2018; status: terminated.
Beyond the preview
Go deeper on NCT02414477.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02414477.